Colorectal liver metastasis: molecular mechanism and interventional therapy
H Zhou, Z Liu, Y Wang, X Wen, EH Amador… - Signal transduction and …, 2022 - nature.com
Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …
The CyberKnife® robotic radiosurgery system in 2010
W Kilby, JR Dooley, G Kuduvalli… - … in cancer research …, 2010 - journals.sagepub.com
This review provides a complete technical description of the CyberKnife® VSI™ System, the
latest addition to the CyberKnife product family, which was released in September 2009 …
latest addition to the CyberKnife product family, which was released in September 2009 …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …
tumor biological characteristics, treatment patterns, and drug selections between gastric …
[HTML][HTML] ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero… - Annals of …, 2016 - Elsevier
Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …
Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic …
TS Hong, JY Wo, BY Yeap, E Ben-Josef… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To evaluate the efficacy and safety of high-dose, hypofractionated proton beam
therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) …
therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) …
Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions
A Filatenkov, J Baker, AMS Mueller, J Kenkel… - Clinical Cancer …, 2015 - AACR
Purpose: The goals of the study were to elucidate the immune mechanisms that contribute to
desirable complete remissions of murine colon tumors treated with single radiation dose of …
desirable complete remissions of murine colon tumors treated with single radiation dose of …
Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma
Purpose: Local tumor growth is a major cause of morbidity and mortality in nearly 30% of
patients with pancreatic ductal adenocarcinoma (PDAC). Radiotherapy is commonly used …
patients with pancreatic ductal adenocarcinoma (PDAC). Radiotherapy is commonly used …
Stereotactic Body Radiotherapy (SBRT) for liver metastasis–clinical outcomes from the international multi-institutional RSSearch® Patient Registry
A Mahadevan, O Blanck, R Lanciano, A Peddada… - Radiation …, 2018 - Springer
Background Stereotactic body radiotherapy (SBRT) is an emerging treatment option for liver
metastases in patients unsuitable for surgery. We investigated factors associated with …
metastases in patients unsuitable for surgery. We investigated factors associated with …
Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling
JA Bridgewater, KA Goodman, A Kalyan… - American Society of …, 2016 - ascopubs.org
Biliary tract cancer, or cholangiocarcinoma, arises from the biliary epithelium of the small
ducts in the periphery of the liver (intrahepatic) and the main ducts of the hilum …
ducts in the periphery of the liver (intrahepatic) and the main ducts of the hilum …
Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice
RD Timmerman, J Herman, LC Cho - Journal of Clinical Oncology, 2014 - ascopubs.org
Stereotactic body radiation therapy (SBRT) is generally a tumor-ablative radiation modality
using essential technologies capable of accurately and precisely damaging the target with a …
using essential technologies capable of accurately and precisely damaging the target with a …